MARKET

VRAX

VRAX

Virax Biolabs Group Ltd
NASDAQ
2.880
-0.100
-3.36%
After Hours: 2.870 -0.01 -0.35% 16:59 08/10 EDT
OPEN
2.990
PREV CLOSE
2.980
HIGH
2.990
LOW
2.790
VOLUME
35.13K
TURNOVER
--
52 WEEK HIGH
21.75
52 WEEK LOW
2.500
MARKET CAP
2.30M
P/E (TTM)
-0.2279
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VRAX last week (0803-0807)?
Weekly Report · 22h ago
Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Barchart · 4d ago
Weekly Report: what happened at VRAX last week (0727-0731)?
Weekly Report · 08/03 09:38
Virax Biolabs Calls August 14 EGM to Approve Major Share Capital Increase
TipRanks · 07/31 12:17
Weekly Report: what happened at VRAX last week (0720-0724)?
Weekly Report · 07/27 09:41
Virax Biolabs files to sell 1.68M ordinary shares for holders
TipRanks · 07/24 20:25
Virax Biolabs Files Prospectus For Offering 1.682M Ordinary Shares
Benzinga · 07/24 20:23
Weekly Report: what happened at VRAX last week (0713-0717)?
Weekly Report · 07/20 09:39
More
About VRAX
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).

Webull offers Virax Biolabs Group Ltd stock information, including NASDAQ: VRAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRAX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRAX stock methods without spending real money on the virtual paper trading platform.